投稿信息
投稿信息
审稿周期
投稿命中率
审稿费用
暂无数据
版面费用
暂无数据
中国人发表比例
2023年中国人文章占该期刊总数量暂无数据 (2022年为100.00%)
自引率
5.0 %
年文章数
786
作者需知
暂无数据
NCBI查询
偏重的研究方向
暂无数据
期刊简介
稿件收录要求
稿件收录要求
Published by Mary Ann Liebert.
ISSN: 1540-658X.
ASSAY and Drug Development Technologies, a new peer-reviewed journal, focuses on early-stage screening techniques and tools that optimize the identification of novel leads and targets for new drug development. In addition to original papers and review papers, ASSAY publishes Novel Insights: preliminary studies in methods and technology, and novel uses of instrumentation. Comprehensive technology "workshops" from manufacturers are within the journal's purview and should conform to guidelines for manuscript submission; technical descriptions, applications, discussion, and appropriate case studies will be included.
ASSAY and Drug Development Technologies, a new peer-reviewed journal, focuses on early-stage screening techniques and tools that optimize the identification of novel leads and targets for new drug development. In addition to original papers and review papers, ASSAY publishes Novel Insights: preliminary studies in methods and technology, and novel uses of instrumentation. Comprehensive technology "workshops" from manufacturers are within the journal's purview and should conform to guidelines for manuscript submission; technical descriptions, applications, discussion, and appropriate case studies will be included.
